Company Filing History:
Years Active: 2016-2019
Title: Harold Michael Shepard: A Pioneer in Hyaluronan Research
Introduction
Harold Michael Shepard is a notable inventor based in San Diego, California, who has made significant contributions to the field of biopharmaceuticals. With a portfolio of four patents, his work focuses primarily on addressing adverse side effects related to hyaluronan therapy, providing innovative solutions that are crucial for patient care.
Latest Patents
Among Harold Shepard's latest patents is a groundbreaking method aimed at mitigating the adverse side effects associated with the administration of anti-hyaluronan agents. His patent outlines specific protocols for the systemic administration of a PEGylated hyaluronan degrading enzyme, especially a PEGylated hyaluronidase. This innovative method not only addresses the adverse effects of systemic administration but also encompasses treatment strategies for hyaluronan-associated diseases, either as a single-agent therapy or in combination with corticosteroids.
Career Highlights
Harold Michael Shepard has developed his career at Halozyme, Inc., a leading biopharmaceutical company recognized for its pioneering work in enzyme technology, particularly focused on hyaluronan. His expertise and dedication have been instrumental in advancing research initiatives that impact patient outcomes in therapeutic settings.
Collaborations
Throughout his career, Harold has collaborated closely with esteemed colleagues such as Gregory Ian Frost and Curtis B. Thompson. Together, they have worked on various projects that seek to enhance treatment methodologies and improve overall patient care in the field of biopharmaceuticals.
Conclusion
In conclusion, Harold Michael Shepard stands out as a prominent inventor in the biopharmaceutical industry. His innovative work on hyaluronan therapies and methodical approaches to alleviate adverse effects exemplify his commitment to improving health outcomes. As his career progresses, Shepard continues to contribute valuable solutions that could redefine treatment standards for numerous conditions associated with hyaluronan.